Immunotherapy is the future of cancer treatment and TapImmune has been leading the charge. CEO Glynn Wilson discusses the advances made in the ovarian and breast cancer. The company is taking a […]
OncoSec Medical Incorporated (NASDAQ: ONCS) was recently granted FDA Fast Track designation to address the large population of non-responders to the current leading checkpoint inhibitor therapies for stage 4 melanoma. The leading […]
TapImmune, a clinical-stage immuno-oncology company developing peptide and gene-based immunotherapeutics for cancer and metastatic disease, announced the receipt of a $3.7 million grant from the U.S. Department of Defense (DoD). The grant […]
Interpace Diagnostics is a company focused on the development and commercialization of molecular diagnostic tests aimed to optimize patient diagnosis and management. The company currently has three commercialized molecular tests: (1) PancraGen, […]
Biocept is a diagnostic company that focuses on developing solutions aimed to optimize outcomes for cancer patients. Their most recent diagnostic comes in the form of a liquid biopsy, developed in an […]
Pieris Pharmaceuticals, Inc., a clinical stage biopharmaceutical company in Boston, is developing Anticalin-based drugs for the treatment of cancer, asthma, anemia and other conditions that show a high unmet medical need. Pieris’ […]
Interested in joining the OneMedNews team? See below for open job opportunities. Journalism/Public Relations freelance writer OneMedNews is looking for a go-getter freelance writer to conduct interviews and write stories for the […]
IN THIS ISSUE: FEATURE: The Case for a Healthcare Futures Market Dennis Purcell and his team at Poliwogg outline the prospects and potential to bring stability to the healthcare market through creating […]
